BlueLinx (BXC) Financials

$67.13 +0.34 (+0.51%)

As of 01:06 PM Eastern

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	53	49	296
Consolidated Net Income / (Loss)	53	49	296
Net Income / (Loss) Continuing Operations	53	49	296
Total Pre-Tax Income	71	82	395
Total Operating Income	88	138	439
Total Gross Profit	489	527	833
Total Revenue	2,953	3,136	4,450
Operating Revenue	2,953	3,136	4,450
Total Cost of Revenue	2,463	2,609	3,617
Operating Cost of Revenue	2,463	2,609	3,617
Total Operating Expenses	402	389	394
Selling, General & Admin Expense	367	360	370
Depreciation Expense	38	32	28
Other Operating Expenses / (Income)	-3.93	-3.93	-
Other Special Charges / (Income)	-0.27	0.00	-0.14
Total Other Income / (Expense), net	-17	-57	-44
Interest & Investment Income	-19	-24	-42
Other Income / (Expense), net	2.48	-33	-2.05
Income Tax Expense	18	33	99
Basic Earnings per Share	$6.22	$5.40	$31.75
Weighted Average Basic Shares Outstanding	8.29M	8.65M	9.06M
Diluted Earnings per Share	$6.19	$5.39	$31.51
Weighted Average Diluted Shares Outstanding	8.29M	8.65M	9.06M
Weighted Average Basic & Diluted Shares Outstanding	8.29M	8.65M	9.06M

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	2.81	5.27	16	14	17	-18	24	24	18	32	60
Consolidated Net Income / (Loss)	2.81	5.27	16	14	17	-18	24	24	18	32	60
Net Income / (Loss) Continuing Operations	2.81	5.27	16	14	17	-18	24	24	18	32	60
Total Pre-Tax Income	4.14	6.97	22	19	23	-8.02	33	32	24	41	81
Total Operating Income	11	12	24	24	28	27	40	39	33	51	91
Total Gross Profit	111	113	126	122	128	118	139	136	134	151	189
Total Revenue	709	711	747	768	726	713	810	816	798	848	1,061
Operating Revenue	709	711	747	768	726	713	810	816	798	848	1,061
Total Cost of Revenue	598	597	622	646	599	594	671	680	664	697	871
Operating Cost of Revenue	598	597	622	646	599	594	671	680	664	697	871
Total Operating Expenses	100	101	102	99	100	91	100	97	101	100	99
Selling, General & Admin Expense	94	93	93	89	92	84	92	90	94	93	93
Depreciation Expense	9.55	9.41	9.53	10	9.43	8.29	8.09	7.95	7.72	7.66	6.69
Other Operating Expenses / (Income)	-3.24	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-	-0.98
Total Other Income / (Expense), net	-6.58	-5.07	-2.39	-4.80	-4.62	-35	-6.17	-6.91	-8.28	-12	-10
Interest & Investment Income	-6.58	-	-4.62	-4.80	-	-	-5.58	-6.31	-	-	-
Income Tax Expense	1.34	1.69	5.62	4.71	5.55	10	9.10	7.72	6.42	8.74	21
Basic Earnings per Share	$0.33	$0.67	$1.88	$1.65	$2.02	($1.98)	$2.72	$2.70	$1.96	$3.95	$6.44
Weighted Average Basic Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M
Diluted Earnings per Share	$0.33	$0.67	$1.87	$1.65	$2.00	($1.96)	$2.71	$2.70	$1.94	$4.46	$6.38
Weighted Average Diluted Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M
Weighted Average Basic & Diluted Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Net Change in Cash & Equivalents	-16	223	214
Net Cash From Operating Activities	85	306	400
Net Cash From Continuing Operating Activities	85	306	400
Net Income / (Loss) Continuing Operations	53	49	296
Consolidated Net Income / (Loss)	53	49	296
Depreciation Expense	38	32	28
Amortization Expense	-2.62	-2.62	-2.78
Non-Cash Adjustments To Reconcile Net Income	7.48	42	9.47
Changes in Operating Assets and Liabilities, net	-11	187	70
Net Cash From Investing Activities	-39	-27	-99
Net Cash From Continuing Investing Activities	-39	-27	-99
Purchase of Property, Plant & Equipment	-40	-28	-36
Acquisitions	0.00	0.30	-64
Sale of Property, Plant & Equipment	0.90	0.36	0.96
Net Cash From Financing Activities	-62	-57	-88
Net Cash From Continuing Financing Activities	-62	-57	-88
Repurchase of Common Equity	-45	-42	-66
Other Financing Activities, net	-17	-14	-21
Cash Interest Paid	45	43	44
Cash Income Taxes Paid	30	19	111

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-57	-21	35	10	-40	52	51	42	77	70	124
Net Cash From Operating Activities	-34	19	62	36	-31	76	78	64	89	154	143
Net Cash From Continuing Operating Activities	-34	19	62	36	-31	76	78	64	89	154	143
Net Income / (Loss) Continuing Operations	2.81	5.27	16	14	17	-18	24	24	18	32	60
Consolidated Net Income / (Loss)	2.81	5.27	16	14	17	-18	24	24	18	32	60
Depreciation Expense	9.55	9.41	9.53	10	9.43	8.29	8.09	7.95	7.72	7.66	6.69
Amortization Expense	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65	-0.66	-0.65	-0.65
Non-Cash Adjustments To Reconcile Net Income	0.08	2.76	0.96	1.41	2.35	32	2.98	1.93	4.57	3.59	2.09
Changes in Operating Assets and Liabilities, net	-46	1.96	36	11	-60	54	43	30	60	112	75
Net Cash From Investing Activities	-3.39	-20	-7.36	-6.31	-5.32	-8.12	-4.84	-4.94	-8.97	-80	-12
Net Cash From Continuing Investing Activities	-3.39	-20	-7.36	-6.31	-5.32	-8.12	-4.84	-4.94	-8.97	-80	-12
Purchase of Property, Plant & Equipment	-5.93	-20	-7.93	-6.45	-5.45	-8.58	-4.90	-5.03	-9.01	-17	-12
Other Investing Activities, net	2.54	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-19	-19	-20	-19	-3.98	-15	-21	-17	-2.70	-4.42	-6.11
Net Cash From Continuing Financing Activities	-19	-19	-20	-19	-3.98	-15	-21	-17	-2.70	-4.42	-6.11
Repurchase of Common Equity	-15	-15	-15	-	-	-13	-18	-	-	-	-
Other Financing Activities, net	-4.30	-3.87	-4.06	-4.88	-3.98	-2.67	-3.59	-5.52	-2.70	-4.42	-6.11
Cash Interest Paid	7.16	16	6.88	15	6.80	15	6.48	15	6.19	19	2.12
Cash Income Taxes Paid	-1.08	6.18	2.13	21	1.34	1.56	6.86	11	0.00	21	29

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Total Assets	1,578	1,538	1,490
Total Current Assets	1,134	1,120	1,077
Cash & Equivalents	506	522	299
Accounts Receivable	226	228	252
Inventories, net	356	344	484
Other Current Assets	47	27	42
Plant, Property, & Equipment, net	250	226	206
Total Noncurrent Assets	194	191	208
Goodwill	55	55	55
Intangible Assets	27	31	35
Noncurrent Deferred & Refundable Income Taxes	51	53	56
Other Noncurrent Operating Assets	61	52	61
Total Liabilities & Shareholders' Equity	1,578	1,538	1,490
Total Liabilities	931	903	900
Total Current Liabilities	234	219	211
Accounts Payable	170	158	152
Current Deferred Revenue	3.94	3.94	3.94
Current Employee Benefit Liabilities	17	14	23
Other Current Liabilities	43	42	33
Total Noncurrent Liabilities	698	685	689
Long-Term Debt	295	294	292
Other Noncurrent Operating Liabilities	402	391	397
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	646	634	590
Total Preferred & Common Equity	646	634	590
Preferred Stock	0.00	0.00	0.00
Total Common Equity	646	634	590
Common Stock	124	165	201
Retained Earnings	522	469	421

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	10/1/2022
Total Assets	1,633	1,611	1,586	1,592	1,585	1,550	1,526	1,534
Total Current Assets	1,166	1,181	1,159	1,173	1,171	1,137	1,114	1,158
Cash & Equivalents	449	526	491	481	470	418	376	229
Accounts Receivable	276	278	274	288	298	294	299	361
Inventories, net	400	341	358	371	364	379	409	536
Other Current Assets	42	37	36	32	40	45	29	32
Plant, Property, & Equipment, net	275	236	232	231	216	210	208	189
Plant, Property & Equipment, gross	462	424	414	407	382	374	366	340
Accumulated Depreciation	187	188	182	176	166	163	158	151
Total Noncurrent Assets	192	194	195	188	199	203	204	187
Goodwill	55	55	55	55	55	55	55	48
Intangible Assets	26	28	29	30	32	33	34	11
Noncurrent Deferred & Refundable Income Taxes	51	51	54	54	55	56	56	61
Other Noncurrent Operating Assets	60	59	57	49	57	59	59	66
Total Liabilities & Shareholders' Equity	1,633	1,611	1,586	1,592	1,585	1,550	1,526	1,534
Total Liabilities	997	955	934	938	954	928	915	976
Total Current Liabilities	281	258	237	249	268	245	228	273
Accounts Payable	213	186	179	172	202	190	177	208
Current Deferred Revenue	3.94	3.94	3.94	3.94	3.94	3.94	3.94	-
Current Employee Benefit Liabilities	14	18	12	14	21	16	15	18
Other Current Liabilities	50	49	42	60	41	34	32	40
Total Noncurrent Liabilities	717	698	696	689	686	683	687	703
Long-Term Debt	295	295	294	294	293	293	293	292
Other Noncurrent Operating Liabilities	421	403	402	395	393	390	394	330
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	636	656	652	653	632	623	611	558
Total Preferred & Common Equity	636	656	652	653	632	623	611	558
Preferred Stock	0.00	0.00	0.00	0.00	-	-	-	-
Total Common Equity	636	656	652	653	632	623	611	558
Common Stock	111	139	151	167	175	191	204	198
Retained Earnings	525	517	501	487	487	463	438	389

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-5.86%	-29.52%	4.05%
EBITDA Growth	-6.77%	-70.76%	-0.69%
EBIT Growth	-14.75%	-75.83%	-0.53%
NOPAT Growth	-19.81%	-75.09%	0.02%
Net Income Growth	9.44%	-83.61%	0.01%
EPS Growth	14.84%	-82.89%	5.07%
Operating Cash Flow Growth	-72.19%	-23.49%	176.02%
Free Cash Flow Firm Growth	-86.04%	-17.75%	122.79%
Invested Capital Growth	7.28%	-30.37%	2.49%
Revenue Q/Q Growth	-0.06%	-4.13%	-2.74%
EBITDA Q/Q Growth	15.88%	-29.37%	-11.47%
EBIT Q/Q Growth	21.83%	-34.96%	-12.29%
NOPAT Q/Q Growth	20.05%	-33.09%	-11.43%
Net Income Q/Q Growth	78.72%	-50.80%	-12.32%
EPS Q/Q Growth	73.88%	-54.36%	-8.43%
Operating Cash Flow Q/Q Growth	-40.01%	-20.44%	51.51%
Free Cash Flow Firm Q/Q Growth	-57.85%	-27.83%	22.70%
Invested Capital Q/Q Growth	2.79%	-10.73%	-15.65%
Profitability Metrics	-	-	-
Gross Margin	16.57%	16.80%	18.72%
EBITDA Margin	4.26%	4.31%	10.38%
Operating Margin	2.97%	4.41%	9.87%
EBIT Margin	3.05%	3.37%	9.82%
Profit (Net Income) Margin	1.80%	1.55%	6.66%
Tax Burden Percent	75.14%	59.27%	75.03%
Interest Burden Percent	78.50%	77.52%	90.33%
Effective Tax Rate	24.86%	40.73%	24.97%
Return on Invested Capital (ROIC)	15.63%	16.58%	57.15%
ROIC Less NNEP Spread (ROIC-NNEP)	21.41%	45.17%	23.82%
Return on Net Nonoperating Assets (RNNOA)	-7.33%	-8.65%	4.99%
Return on Equity (ROE)	8.29%	7.93%	62.14%
Cash Return on Invested Capital (CROIC)	8.60%	52.39%	54.69%
Operating Return on Assets (OROA)	5.78%	6.98%	31.13%
Return on Assets (ROA)	3.41%	3.21%	21.10%
Return on Common Equity (ROCE)	8.29%	7.93%	62.14%
Return on Equity Simple (ROE_SIMPLE)	8.22%	7.65%	50.20%
Net Operating Profit after Tax (NOPAT)	66	82	329
NOPAT Margin	2.23%	2.62%	7.40%
Net Nonoperating Expense Percent (NNEP)	-5.79%	-28.59%	33.33%
Return On Investment Capital (ROIC_SIMPLE)	6.99%	8.84%	37.33%
Cost of Revenue to Revenue	83.43%	83.20%	81.28%
SG&A Expenses to Revenue	12.44%	11.49%	8.32%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.60%	12.39%	8.85%
Earnings before Interest and Taxes (EBIT)	90	106	437
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	126	135	462
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.34	1.57	1.09
Price to Tangible Book Value (P/TBV)	1.54	1.81	1.29
Price to Revenue (P/Rev)	0.29	0.32	0.14
Price to Earnings (P/E)	16.37	20.47	2.17
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	6.11%	4.89%	46.10%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.88	1.09
Enterprise Value to Revenue (EV/Rev)	0.22	0.24	0.14
Enterprise Value to EBITDA (EV/EBITDA)	5.23	5.67	1.38
Enterprise Value to EBIT (EV/EBIT)	7.31	7.25	1.46
Enterprise Value to NOPAT (EV/NOPAT)	10.01	9.33	1.93
Enterprise Value to Operating Cash Flow (EV/OCF)	7.73	2.50	1.59
Enterprise Value to Free Cash Flow (EV/FCFF)	18.19	2.95	2.02
Leverage & Solvency	-	-	-
Debt to Equity	0.46	0.46	0.50
Long-Term Debt to Equity	0.46	0.46	0.50
Financial Leverage	-0.34	-0.19	0.21
Leverage Ratio	2.43	2.47	2.95
Compound Leverage Factor	1.91	1.92	2.66
Debt to Total Capital	31.34%	31.65%	33.14%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	31.34%	31.65%	33.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	68.66%	68.35%	66.86%
Debt to EBITDA	2.34	2.17	0.63
Net Debt to EBITDA	-1.67	-1.69	-0.01
Long-Term Debt to EBITDA	2.34	2.17	0.63
Debt to NOPAT	4.48	3.58	0.89
Net Debt to NOPAT	-3.20	-2.78	-0.02
Long-Term Debt to NOPAT	4.48	3.58	0.89
Altman Z-Score	3.77	4.06	5.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	4.85	5.13	5.11
Quick Ratio	3.13	3.43	2.61
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	36	259	315
Operating Cash Flow to CapEx	217.24%	1,127.58%	1,146.26%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.90	2.07	3.17
Accounts Receivable Turnover	13.00	13.07	15.06
Inventory Turnover	7.04	6.30	7.44
Fixed Asset Turnover	12.42	14.53	0.00
Accounts Payable Turnover	15.01	16.86	21.82
Days Sales Outstanding (DSO)	28.08	27.93	24.24
Days Inventory Outstanding (DIO)	51.83	57.91	49.08
Days Payable Outstanding (DPO)	24.31	21.65	16.73
Cash Conversion Cycle (CCC)	55.59	64.18	56.59
Capital & Investment Metrics	-	-	-
Invested Capital	436	406	584
Invested Capital Turnover	7.01	6.34	7.72
Increase / (Decrease) in Invested Capital	30	-177	14
Enterprise Value (EV)	659	765	636
Market Capitalization	869	993	643
Book Value per Share	$77.13	$72.35	$65.30
Tangible Book Value per Share	$67.32	$62.52	$55.30
Total Capital	942	928	882
Total Debt	295	294	292
Total Long-Term Debt	295	294	292
Net Debt	-211	-228	-6.52
Capital Expenditures (CapEx)	39	27	35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	395	380	567
Debt-free Net Working Capital (DFNWC)	900	902	866
Net Working Capital (NWC)	900	902	866
Net Nonoperating Expense (NNE)	13	34	33
Net Nonoperating Obligations (NNO)	-211	-228	-6.52
Total Depreciation and Amortization (D&A)	36	29	25
Debt-free, Cash-free Net Working Capital to Revenue	13.37%	12.12%	12.75%
Debt-free Net Working Capital to Revenue	30.49%	28.75%	19.47%
Net Working Capital to Revenue	30.49%	28.75%	19.47%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$6.22	$5.40	$31.75
Adjusted Weighted Average Basic Shares Outstanding	8.29M	8.65M	9.06M
Adjusted Diluted Earnings per Share	$6.19	$5.39	$31.51
Adjusted Weighted Average Diluted Shares Outstanding	8.29M	8.65M	9.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.29M	8.65M	9.06M
Normalized Net Operating Profit after Tax (NOPAT)	66	82	329
Normalized NOPAT Margin	2.22%	2.62%	7.40%
Pre Tax Income Margin	2.39%	2.61%	8.87%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	85.28%	86.81%	22.43%

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.34%	-0.27%	-7.74%	-5.83%	-8.98%	-15.95%	-23.64%	-34.16%	-38.73%	-12.87%	9.26%
EBITDA Growth	-46.15%	456.07%	-24.45%	-27.26%	-6.51%	-93.49%	-52.13%	-58.25%	-80.43%	-49.83%	24.24%
EBIT Growth	-61.24%	419.09%	-32.80%	-38.06%	-13.32%	-107.53%	-57.12%	-62.95%	-83.47%	-53.63%	26.96%
NOPAT Growth	-65.44%	-52.15%	-38.40%	-39.59%	-12.12%	-52.63%	-56.87%	-62.87%	-83.24%	-51.29%	26.65%
Net Income Growth	-83.96%	129.09%	-34.31%	-41.40%	-1.80%	-156.66%	-59.03%	-65.67%	-86.65%	-56.55%	26.08%
EPS Growth	-83.50%	134.18%	-31.00%	-38.89%	3.09%	-143.95%	-57.52%	-63.90%	-85.29%	-39.40%	34.60%
Operating Cash Flow Growth	-8.91%	-75.19%	-20.41%	-44.19%	-135.00%	-51.02%	-45.58%	-36.60%	3,876.98%	749.27%	36.78%
Free Cash Flow Firm Growth	-111.23%	-110.44%	-81.59%	-79.34%	-60.04%	655.55%	652.09%	665.52%	1,906.97%	124.65%	54.65%
Invested Capital Growth	3.54%	7.28%	-6.83%	-8.48%	-11.62%	-30.37%	-34.21%	-34.44%	-25.66%	2.49%	19.95%
Revenue Q/Q Growth	-0.20%	-4.90%	-2.74%	5.80%	1.92%	-12.03%	-0.73%	2.26%	-5.88%	-20.08%	-14.41%
EBITDA Q/Q Growth	-6.70%	-40.11%	5.45%	-8.60%	863.44%	-91.86%	1.53%	17.47%	-32.96%	-40.12%	-11.45%
EBIT Q/Q Growth	-12.71%	-53.20%	10.08%	-13.81%	818.65%	-109.86%	1.46%	20.61%	-37.59%	-43.85%	-12.34%
NOPAT Q/Q Growth	-20.28%	-48.81%	-0.90%	-14.53%	10.37%	-34.10%	-2.82%	24.34%	-40.50%	-40.00%	-16.35%
Net Income Q/Q Growth	-46.79%	-67.08%	11.72%	-18.04%	196.51%	-174.33%	-0.34%	37.36%	-44.31%	-46.25%	-16.50%
EPS Q/Q Growth	-50.75%	-64.17%	13.33%	-17.50%	202.04%	-172.32%	0.37%	39.18%	-56.50%	-30.09%	-14.71%
Operating Cash Flow Q/Q Growth	-280.90%	-69.65%	72.52%	214.99%	-141.21%	-2.64%	20.97%	-27.89%	-42.33%	8.17%	40.92%
Free Cash Flow Firm Q/Q Growth	54.89%	-141.91%	-18.70%	-26.92%	-58.07%	-26.09%	-8.76%	41.34%	692.69%	154.01%	6.54%
Invested Capital Q/Q Growth	10.69%	2.79%	-6.87%	-2.28%	14.69%	-10.73%	-8.52%	-5.64%	-9.64%	-15.65%	-8.84%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.67%	15.95%	16.82%	15.94%	17.58%	16.62%	17.19%	16.64%	16.74%	17.83%	17.85%
EBITDA Margin	2.77%	2.96%	4.70%	4.34%	5.02%	0.53%	5.74%	5.61%	4.89%	6.86%	9.16%
Operating Margin	1.51%	1.69%	3.22%	3.10%	3.81%	3.82%	4.90%	4.79%	4.08%	6.03%	8.55%
EBIT Margin	1.51%	1.73%	3.51%	3.10%	3.81%	-0.54%	4.82%	4.72%	4.00%	6.03%	8.59%
Profit (Net Income) Margin	0.40%	0.74%	2.14%	1.87%	2.41%	-2.54%	3.01%	3.00%	2.23%	3.77%	5.61%
Tax Burden Percent	67.69%	75.69%	74.04%	75.27%	75.91%	225.96%	72.81%	76.01%	73.50%	78.54%	73.79%
Interest Burden Percent	38.64%	56.70%	82.40%	79.87%	83.29%	208.34%	85.72%	83.61%	75.92%	79.63%	88.53%
Effective Tax Rate	32.31%	24.31%	25.96%	24.73%	24.09%	0.00%	27.19%	23.99%	26.50%	21.46%	26.21%
Return on Invested Capital (ROIC)	6.34%	8.98%	16.00%	14.79%	17.85%	16.93%	20.34%	20.42%	19.12%	36.58%	45.53%
ROIC Less NNEP Spread (ROIC-NNEP)	8.95%	10.73%	16.87%	17.04%	20.44%	48.61%	41.59%	12.58%	10.00%	28.38%	42.06%
Return on Net Nonoperating Assets (RNNOA)	-2.37%	-3.68%	-5.35%	-4.31%	-4.38%	-9.31%	-1.48%	1.50%	1.21%	5.94%	21.46%
Return on Equity (ROE)	3.97%	5.31%	10.65%	10.49%	13.47%	7.61%	18.86%	21.92%	20.33%	42.52%	66.99%
Cash Return on Invested Capital (CROIC)	7.57%	8.60%	19.54%	22.86%	28.41%	52.39%	62.65%	67.17%	63.57%	54.69%	40.51%
Operating Return on Assets (OROA)	2.75%	3.28%	6.49%	5.97%	7.49%	-1.12%	10.12%	10.86%	10.32%	19.13%	28.72%
Return on Assets (ROA)	0.72%	1.41%	3.96%	3.59%	4.74%	-5.27%	6.31%	6.90%	5.76%	11.96%	18.76%
Return on Common Equity (ROCE)	3.97%	5.31%	10.65%	10.49%	13.47%	7.61%	18.86%	21.92%	20.33%	42.52%	66.99%
Return on Equity Simple (ROE_SIMPLE)	6.04%	0.00%	4.53%	5.84%	7.38%	0.00%	15.62%	21.48%	29.57%	0.00%	60.57%
Net Operating Profit after Tax (NOPAT)	7.26	9.11	18	18	21	19	29	30	24	40	67
NOPAT Margin	1.02%	1.28%	2.38%	2.34%	2.89%	2.67%	3.56%	3.64%	3.00%	4.74%	6.31%
Net Nonoperating Expense Percent (NNEP)	-2.61%	-1.75%	-0.87%	-2.24%	-2.59%	-31.68%	-21.25%	7.84%	9.11%	8.20%	3.47%
Return On Investment Capital (ROIC_SIMPLE)	0.78%	0.97%	-	-	-	2.05%	-	-	-	4.55%	-
Cost of Revenue to Revenue	84.33%	84.05%	83.18%	84.06%	82.42%	83.38%	82.81%	83.36%	83.26%	82.17%	82.15%
SG&A Expenses to Revenue	13.27%	13.11%	12.46%	11.64%	12.61%	11.78%	11.42%	11.00%	11.82%	11.01%	8.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.16%	14.26%	13.60%	12.83%	13.77%	12.81%	12.30%	11.85%	12.66%	11.80%	9.30%
Earnings before Interest and Taxes (EBIT)	11	12	26	24	28	-3.85	39	38	32	51	91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	20	21	35	33	36	3.78	46	46	39	58	97
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.00	1.34	1.36	1.24	1.75	1.57	1.17	1.37	1.01	1.09	1.03
Price to Tangible Book Value (P/TBV)	1.15	1.54	1.56	1.42	2.01	1.81	1.36	1.59	1.18	1.29	1.16
Price to Revenue (P/Rev)	0.22	0.29	0.30	0.27	0.37	0.32	0.23	0.24	0.16	0.14	0.13
Price to Earnings (P/E)	16.54	16.37	29.99	21.17	23.68	20.47	7.49	6.37	3.41	2.17	1.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.05%	6.11%	3.33%	4.72%	4.22%	4.89%	13.35%	15.69%	29.33%	46.10%	58.60%
Enterprise Value to Invested Capital (EV/IC)	1.00	1.51	1.56	1.34	2.05	1.88	1.24	1.46	1.01	1.09	1.03
Enterprise Value to Revenue (EV/Rev)	0.16	0.22	0.22	0.20	0.31	0.24	0.17	0.21	0.13	0.14	0.16
Enterprise Value to EBITDA (EV/EBITDA)	4.52	5.23	6.07	5.08	7.20	5.67	2.94	3.02	1.75	1.38	1.36
Enterprise Value to EBIT (EV/EBIT)	6.82	7.31	8.93	7.03	9.42	7.25	3.46	3.41	1.91	1.46	1.43
Enterprise Value to NOPAT (EV/NOPAT)	9.19	10.01	12.04	9.13	11.96	9.33	4.59	4.53	2.52	1.93	1.91
Enterprise Value to Operating Cash Flow (EV/OCF)	5.85	7.73	4.65	3.86	5.13	2.50	1.46	1.62	1.09	1.59	2.69
Enterprise Value to Free Cash Flow (EV/FCFF)	13.42	18.19	7.68	5.59	6.76	2.95	1.57	1.72	1.35	2.02	2.77
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.46	0.46	0.45	0.45	0.45	0.46	0.46	0.47	0.48	0.50	0.65
Long-Term Debt to Equity	0.46	0.46	0.45	0.45	0.45	0.46	0.46	0.47	0.48	0.50	0.65
Financial Leverage	-0.26	-0.34	-0.32	-0.25	-0.21	-0.19	-0.04	0.12	0.12	0.21	0.51
Leverage Ratio	2.50	2.43	2.48	2.46	2.47	2.47	2.62	2.73	2.77	2.95	3.26
Compound Leverage Factor	0.97	1.38	2.05	1.96	2.05	5.15	2.25	2.28	2.11	2.35	2.88
Debt to Total Capital	31.71%	31.34%	31.01%	31.10%	31.04%	31.65%	31.72%	32.00%	32.40%	33.14%	39.46%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	31.71%	31.34%	31.01%	31.10%	31.04%	31.65%	31.72%	32.00%	32.40%	33.14%	39.46%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	68.29%	68.66%	68.99%	68.90%	68.96%	68.35%	68.28%	68.00%	67.60%	66.86%	60.54%
Debt to EBITDA	2.77	2.34	2.71	2.45	2.22	2.17	1.53	1.22	0.96	0.63	0.70
Net Debt to EBITDA	-1.44	-1.67	-2.13	-1.64	-1.41	-1.69	-0.92	-0.52	-0.27	-0.01	0.26
Long-Term Debt to EBITDA	2.77	2.34	2.71	2.45	2.22	2.17	1.53	1.22	0.96	0.63	0.70
Debt to NOPAT	5.64	4.48	5.38	4.41	3.68	3.58	2.39	1.82	1.39	0.89	0.98
Net Debt to NOPAT	-2.93	-3.20	-4.22	-2.95	-2.35	-2.78	-1.44	-0.78	-0.40	-0.02	0.36
Long-Term Debt to NOPAT	5.64	4.48	5.38	4.41	3.68	3.58	2.39	1.82	1.39	0.89	0.98
Altman Z-Score	3.30	3.61	3.58	3.61	3.84	3.82	3.72	4.01	4.16	4.62	4.58
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.16	4.85	4.58	4.88	4.71	5.13	4.37	4.65	4.88	5.11	4.24
Quick Ratio	2.58	3.13	3.12	3.22	3.09	3.43	2.86	2.91	2.96	2.61	2.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.24	-20	49	60	82	196	266	291	206	26	-48
Operating Cash Flow to CapEx	-571.61%	92.70%	838.76%	567.67%	-585.24%	897.83%	1,604.76%	1,298.64%	991.70%	935.43%	1,180.51%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	17.80	0.00	0.00	0.00	26.79	0.00	-4.60
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	-6.73	0.00	0.00	0.00	11.57	0.00	13.65
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-7.88	0.00	0.00	0.00	10.41	0.00	12.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.82	1.90	1.85	1.92	1.97	2.07	2.10	2.30	2.58	3.17	3.34
Accounts Receivable Turnover	10.41	13.00	10.27	10.63	10.44	13.07	9.94	9.83	9.91	15.06	12.97
Inventory Turnover	6.39	7.04	6.98	6.81	6.52	6.30	6.03	6.09	6.73	7.44	7.61
Fixed Asset Turnover	11.59	12.42	13.09	13.63	13.96	14.53	16.19	18.10	20.45	0.00	0.00
Accounts Payable Turnover	12.80	15.01	12.66	13.58	14.59	16.86	13.21	13.56	16.07	21.82	17.68
Days Sales Outstanding (DSO)	35.05	28.08	35.56	34.35	34.96	27.93	36.71	37.15	36.81	24.24	28.14
Days Inventory Outstanding (DIO)	57.09	51.83	52.28	53.59	55.98	57.91	60.58	59.96	54.24	49.08	47.96
Days Payable Outstanding (DPO)	28.52	24.31	28.82	26.87	25.02	21.65	27.62	26.92	22.72	16.73	20.65
Cash Conversion Cycle (CCC)	63.63	55.59	59.01	61.07	65.92	64.18	69.67	70.19	68.33	56.59	55.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	482	436	424	455	466	406	455	498	527	584	692
Invested Capital Turnover	6.19	7.01	6.72	6.33	6.17	6.34	5.71	5.61	6.38	7.72	7.21
Increase / (Decrease) in Invested Capital	17	30	-31	-42	-61	-177	-237	-261	-182	14	115
Enterprise Value (EV)	482	659	660	609	955	765	563	727	532	636	711
Market Capitalization	635	869	891	806	1,142	993	739	852	616	643	576
Book Value per Share	$76.69	$77.13	$76.90	$75.31	$75.41	$72.35	$70.14	$68.52	$67.42	$65.30	$60.08
Tangible Book Value per Share	$66.89	$67.32	$67.14	$65.60	$65.59	$62.52	$60.46	$58.81	$57.57	$55.30	$53.71
Total Capital	932	942	950	947	947	928	925	916	904	882	921
Total Debt	295	295	295	294	294	294	293	293	293	292	363
Total Long-Term Debt	295	295	295	294	294	294	293	293	293	292	363
Net Debt	-154	-211	-232	-197	-187	-228	-176	-125	-83	-6.52	134
Capital Expenditures (CapEx)	5.93	20	7.36	6.31	5.32	8.42	4.84	4.94	8.97	16	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	437	395	397	430	442	380	433	474	509	567	656
Debt-free Net Working Capital (DFNWC)	886	900	924	921	924	902	903	893	885	866	885
Net Working Capital (NWC)	886	900	924	921	924	902	903	893	885	866	885
Net Nonoperating Expense (NNE)	4.45	3.83	1.77	3.61	3.51	37	4.49	5.25	6.09	8.18	7.44
Net Nonoperating Obligations (NNO)	-154	-211	-232	-197	-187	-228	-176	-125	-83	-6.52	134
Total Depreciation and Amortization (D&A)	8.90	8.75	8.88	9.47	8.78	7.63	7.44	7.30	7.06	7.01	6.04
Debt-free, Cash-free Net Working Capital to Revenue	14.88%	13.37%	13.45%	14.25%	14.43%	12.12%	13.25%	13.47%	12.90%	12.75%	14.33%
Debt-free Net Working Capital to Revenue	30.17%	30.49%	31.26%	30.53%	30.13%	28.75%	27.60%	25.34%	22.44%	19.47%	19.34%
Net Working Capital to Revenue	30.17%	30.49%	31.26%	30.53%	30.13%	28.75%	27.60%	25.34%	22.44%	19.47%	19.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.33	$0.67	$1.88	$1.65	$2.02	($1.98)	$2.72	$2.70	$1.96	$3.95	$6.44
Adjusted Weighted Average Basic Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M
Adjusted Diluted Earnings per Share	$0.33	$0.67	$1.87	$1.65	$2.00	($1.96)	$2.71	$2.70	$1.94	$4.46	$6.38
Adjusted Weighted Average Diluted Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.02M	8.29M	8.38M	8.53M	8.66M	8.65M	8.77M	9.00M	9.09M	9.06M	9.04M
Normalized Net Operating Profit after Tax (NOPAT)	7.26	9.11	18	18	21	19	29	30	24	40	67
Normalized NOPAT Margin	1.02%	1.28%	2.38%	2.34%	2.89%	2.67%	3.56%	3.64%	3.00%	4.74%	6.31%
Pre Tax Income Margin	0.58%	0.98%	2.89%	2.48%	3.17%	-1.13%	4.13%	3.94%	3.04%	4.80%	7.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	5.98	0.00	0.00	0.00	4.15	0.00	8.72
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	4.54	0.00	0.00	0.00	3.11	0.00	6.41
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	4.83	0.00	0.00	0.00	2.99	0.00	7.56
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	3.39	0.00	0.00	0.00	1.94	0.00	5.25
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	156.92%	85.28%	144.00%	118.32%	0.00%	86.81%	29.72%	8.67%	0.00%	22.43%	19.66%

Frequently Asked Questions About BlueLinx's Financials

When does BlueLinx's financial year end?

According to the most recent income statement we have on file, BlueLinx's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has BlueLinx's net income changed over the last 2 years?

BlueLinx's net income appears to be on a downward trend, with a most recent value of $53.12 million in 2024, falling from $296.18 million in 2022. The previous period was $48.54 million in 2023. Check out BlueLinx's forecast to explore projected trends and price targets.

What is BlueLinx's operating income?

BlueLinx's total operating income in 2024 was $87.57 million, based on the following breakdown:

Total Gross Profit: $489.14 million
Total Operating Expenses: $401.57 million

How has BlueLinx revenue changed over the last 2 years?

Over the last 2 years, BlueLinx's total revenue changed from $4.45 billion in 2022 to $2.95 billion in 2024, a change of -33.7%.

How much debt does BlueLinx have?

BlueLinx's total liabilities were at $931.28 million at the end of 2024, a 3.1% increase from 2023, and a 3.5% increase since 2022.

How much cash does BlueLinx have?

In the past 2 years, BlueLinx's cash and equivalents has ranged from $298.94 million in 2022 to $521.74 million in 2023, and is currently $505.62 million as of their latest financial filing in 2024.

How has BlueLinx's book value per share changed over the last 2 years?

Over the last 2 years, BlueLinx's book value per share changed from 65.30 in 2022 to 77.13 in 2024, a change of 18.1%.

Related Companies

This page (NYSE:BXC) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BlueLinx (BXC) Financials

Frequently Asked Questions About BlueLinx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BlueLinx (BXC) Financials

Annual Income Statements for BlueLinx

Quarterly Income Statements for BlueLinx

Annual Cash Flow Statements for BlueLinx

Quarterly Cash Flow Statements for BlueLinx

Annual Balance Sheets for BlueLinx

Quarterly Balance Sheets for BlueLinx

Annual Metrics And Ratios for BlueLinx

Quarterly Metrics And Ratios for BlueLinx

Frequently Asked Questions About BlueLinx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools